Advances in Therapeutic Peptides Separation and Purification DOI Creative Commons
Othman Al Musaimi, Da’san M. M. Jaradat

Separations, Journal Year: 2024, Volume and Issue: 11(8), P. 233 - 233

Published: July 29, 2024

Peptides are gaining prominence in various fields, including the pharmaceutical industry. To meet regulatory requirements, they must achieve a certain purity threshold to ensure safe administration. Numerous purification technologies have been employed purify peptides, aiming reduce cost and time while being sustainable efficient. These include chromatography, magnetic nanoparticles, isoelectric focusing, membrane filtration. The physicochemical properties of peptides main driving element behind these technologies. While chromatographic separation remains gold standard for peptide purification, with models predict elution behaviors other demonstrated their capability performance established methodologies, better productivity reduced cost. This opens door further investigational studies assess outcomes potentially introduce new techniques purification. In this review, we examine terms efficiency ability sustainability concluding remarks an outlook on future advancements.

Language: Английский

FDA's stamp of approval: Unveiling peptide breakthroughs in cardiovascular diseases, ACE, HIV, CNS, and beyond DOI Creative Commons
Othman Al Musaimi

Journal of Peptide Science, Journal Year: 2024, Volume and Issue: unknown

Published: June 17, 2024

Peptides exhibit significant specificity and effective interaction with therapeutic targets, positioning themselves as key players in the global pharmaceutical market. They offer potential treatments for a wide range of diseases, including those that pose challenges. Notably, peptide trofinetide (Daybue) marked groundbreaking achievement by providing first-ever cure Rett syndrome, several peptides have secured FDA approval first-in-class medications. Furthermore, are expanding their presence areas traditionally dominated either small or large molecules. A noteworthy example is motixafortide (Aphexda) first peptide-based chemokine antagonist. Here, focus will be on analysis FDA-approved peptides, particularly targeting cardiovascular human immunodeficiency, central nervous system various other intriguing classes addressing conditions such osteoporosis, thrombocytopenia, Cushing's disease, hypoglycemia, among others. The review explore chemical structures indications modes action, developmental trajectory, adverse effects.

Language: Английский

Citations

5

Cyclic peptides: a powerful instrument for advancing biomedical nanotechnologies and drug development DOI Creative Commons

Paul Cristian Martian,

Mihaela Tertiş, Denisa Leonte

et al.

Journal of Pharmaceutical and Biomedical Analysis, Journal Year: 2024, Volume and Issue: 252, P. 116488 - 116488

Published: Sept. 27, 2024

Language: Английский

Citations

5

Lignocellulosic biomass-based glycoconjugates for diverse biotechnological applications DOI
Cristiano E. Rodrigues Reis, Thais S. Milessi, Márcio Daniel Nicodemos Ramos

et al.

Biotechnology Advances, Journal Year: 2023, Volume and Issue: 68, P. 108209 - 108209

Published: July 17, 2023

Language: Английский

Citations

12

An Insight into the Pharmacology of Sulphur Containing Peptide Drugs DOI
Anamika Sharma, Lakhwinder Singh

European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 271, P. 116456 - 116456

Published: April 28, 2024

Language: Английский

Citations

4

Advances in Therapeutic Peptides Separation and Purification DOI Creative Commons
Othman Al Musaimi, Da’san M. M. Jaradat

Separations, Journal Year: 2024, Volume and Issue: 11(8), P. 233 - 233

Published: July 29, 2024

Peptides are gaining prominence in various fields, including the pharmaceutical industry. To meet regulatory requirements, they must achieve a certain purity threshold to ensure safe administration. Numerous purification technologies have been employed purify peptides, aiming reduce cost and time while being sustainable efficient. These include chromatography, magnetic nanoparticles, isoelectric focusing, membrane filtration. The physicochemical properties of peptides main driving element behind these technologies. While chromatographic separation remains gold standard for peptide purification, with models predict elution behaviors other demonstrated their capability performance established methodologies, better productivity reduced cost. This opens door further investigational studies assess outcomes potentially introduce new techniques purification. In this review, we examine terms efficiency ability sustainability concluding remarks an outlook on future advancements.

Language: Английский

Citations

4